263 related articles for article (PubMed ID: 23022807)
1. Association of lead exposure, serum uric acid and parameters of renal function in Nigerian lead-exposed workers.
Alasia DD; Emem-Chioma PC; Wokoma FS
Int J Occup Environ Med; 2010 Oct; 1(4):182-90. PubMed ID: 23022807
[TBL] [Abstract][Full Text] [Related]
2. Occupational and environmental lead exposure in Port Harcourt, Nigeria: analysis of its association with renal function indices.
Alasia DD; Emem-Chioma PC; Wokoma FS
Niger J Med; 2010; 19(4):407-14. PubMed ID: 21526629
[TBL] [Abstract][Full Text] [Related]
3. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate.
See LC; Kuo CF; Chuang FH; Li HY; Chen YM; Chen HW; Yu KH
J Rheumatol; 2009 Aug; 36(8):1691-8. PubMed ID: 19531754
[TBL] [Abstract][Full Text] [Related]
4. Elderly renal transplant recipients and renal dysfunction: a risk factor for hyperuricemia.
Einollahi B; Einollahi H; Rostami Z
Exp Clin Transplant; 2011 Dec; 9(6):376-80. PubMed ID: 22142044
[TBL] [Abstract][Full Text] [Related]
5. Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.
Neri L; Rocca Rey LA; Lentine KL; Hinyard LJ; Pinsky B; Xiao H; Dukes J; Schnitzler MA
Am J Kidney Dis; 2011 Sep; 58(3):398-408. PubMed ID: 21783292
[TBL] [Abstract][Full Text] [Related]
6. Lead-induced oxidative stress adversely affects health of the occupational workers.
Khan DA; Qayyum S; Saleem S; Khan FA
Toxicol Ind Health; 2008 Oct; 24(9):611-8. PubMed ID: 19106128
[TBL] [Abstract][Full Text] [Related]
7. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
8. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of biomarkers of exposure to inorganic mercury, lead, or cadmium in controlling occupational and environmental risks of nephrotoxicity.
Roels HA; Hoet P; Lison D
Ren Fail; 1999; 21(3-4):251-62. PubMed ID: 10416202
[TBL] [Abstract][Full Text] [Related]
10. Low-level lead exposure and the prevalence of gout: an observational study.
Krishnan E; Lingala B; Bhalla V
Ann Intern Med; 2012 Aug; 157(4):233-41. PubMed ID: 22910934
[TBL] [Abstract][Full Text] [Related]
11. Relationship between blood lead levels and renal function in lead battery workers.
Wang VS; Lee MT; Chiou JY; Guu CF; Wu CC; Wu TN; Lai JS
Int Arch Occup Environ Health; 2002 Oct; 75(8):569-75. PubMed ID: 12373319
[TBL] [Abstract][Full Text] [Related]
12. Renal effects of low dose aspirin in elderly patients.
Segal R; Lubart E; Leibovitz A; Iaina A; Caspi D
Isr Med Assoc J; 2006 Oct; 8(10):679-82. PubMed ID: 17125112
[TBL] [Abstract][Full Text] [Related]
13. Lead blood concentrations and renal function evaluation: study in an exposed Mexican population.
Hernández-Serrato MI; Fortoul TI; Rojas-Martínez R; Mendoza-Alvarado LR; Canales-Treviño L; Bochichio-Riccardelli T; Avila-Costa MR; Olaiz-Fernández G
Environ Res; 2006 Feb; 100(2):227-31. PubMed ID: 16442996
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hyperuricemia and its association with antihypertensive treatment in hypertensive patients in Taiwan.
Lin CS; Lee WL; Hung YJ; Lee DY; Chen KF; Chi WC; Chang SC
Int J Cardiol; 2012 Apr; 156(1):41-6. PubMed ID: 21095025
[TBL] [Abstract][Full Text] [Related]
15. Association of uric acid with risk factors for chronic kidney disease and metabolic syndrome in patients with essential hypertension.
Seki S; Tsutsui K; Fujii T; Yamazaki K; Anzawa R; Yoshimura M
Clin Exp Hypertens; 2010; 32(5):270-7. PubMed ID: 20662727
[TBL] [Abstract][Full Text] [Related]
16. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
[TBL] [Abstract][Full Text] [Related]
17. Low-level lead exposure, renal function and blood pressure.
Staessen J
Verh K Acad Geneeskd Belg; 1995; 57(6):527-74. PubMed ID: 8686371
[TBL] [Abstract][Full Text] [Related]
18. Assessment of some renal indices in people occupationally exposed to lead.
Onuegbu AJ; Olisekodiaka MJ; Nwaba EI; Adeyeye AD; Akinola FF
Toxicol Ind Health; 2011 Jun; 27(5):475-9. PubMed ID: 21310779
[TBL] [Abstract][Full Text] [Related]
19. Uric acid: a surrogate of insulin resistance in older women.
Chen LK; Lin MH; Lai HY; Hwang SJ; Chiou ST
Maturitas; 2008 Jan; 59(1):55-61. PubMed ID: 18082342
[TBL] [Abstract][Full Text] [Related]
20. Association of uric acid with change in kidney function in healthy normotensive individuals.
Bellomo G; Venanzi S; Verdura C; Saronio P; Esposito A; Timio M
Am J Kidney Dis; 2010 Aug; 56(2):264-72. PubMed ID: 20385436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
